08/07/2025
https://www.facebook.com/100052456513487/posts/1311936727231532/?sfnsn=mo&mibextid=6aamW6
Cancer does not just crave sugar and glutamine. Many tumors also develop a voracious appetite for fat.
Fatty acids, normally a healthy part of our biology, provide energy, build hormones, and support immune and brain function. But in cancer, these same fats can be hijacked. Tumor cells rewire how they use fats to build themselves faster, outmaneuver treatments, and hide from the immune system. This process, known as lipid metabolic reprogramming, is both a survival trick and a dangerous vulnerability.
Cancer cells adapt to burn fat when sugar is scarce. They also boost fat production, absorb more fat from the bloodstream, and manipulate fat-based signals to suppress immune attacks. This makes fat a fuel source, a shield, and a weapon. If we can understand this dependency, we may also be able to disrupt it.
🔵Why Some Fats Should Be Minimized in Cancer
Not all fats are created equal. A 2025 study in Nature Metabolism found that animal-derived saturated fats like butter, lard, and beef tallow helped tumors grow faster in mice.
These fats caused toxic fat byproducts, specifically long-chain acylcarnitines such as CAR18:0, to build up. These byproducts interfered with the powerhouses of immune cells (mitochondria), weakening their ability to destroy cancer.
Plant-based fats told a different story. Fats from olive oil, palm oil, and coconut oil did not cause the same immune suppression. In fact, they helped preserve the function of cytotoxic T cells—specialized immune cells that kill cancer cells—by maintaining levels of a protective protein called c-Myc.
What this means is simple: Tumors aren’t just using fats. They are using the wrong fats to help themselves and hurt us. By reducing harmful fats and emphasizing protective ones, we may be able to slow cancer and support our immune system.
Study 🔬 🔗 https://rdcu.be/ezItH
🔵Additional Nuance: Monounsaturated vs. Polyunsaturated Fats
Even among healthy fats, there are key differences. Monounsaturated fats, such as those found in olive oil and avocados, are generally considered anti-inflammatory and heart-healthy. Polyunsaturated fats include both omega-3 and omega-6 fatty acids. While some omega-6 fats can drive inflammation, omega-3 fatty acids like alpha-linolenic acid, found in walnuts and milled flaxseed, have demonstrated anti-inflammatory and anti-cancer properties.
Omega-3 fats may also promote a specialized form of cancer cell death called ferroptosis. Ferroptosis occurs when iron within cells reacts with fats to create damaging molecules called lipid peroxides. These molecules destroy the membranes of cancer cells, leading to cell death. Encouraging this process through diet is still under investigation, but researchers are increasingly viewing omega-3 fats as a strategic part of anti-cancer nutrition.
Among the omega-3 fats, two of the most studied are DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid). Some laboratory studies suggest DHA may be more effective than EPA in promoting oxidative stress and cell death in certain cancer types, such as colon and breast cancer. However, EPA also plays important roles by reducing inflammation and blocking new blood vessel growth that tumors need. Clinical studies typically use a combination of both, and there is no clear consensus that a high DHA-to-EPA ratio is better for all patients. Algal oil, which is a plant-based source of DHA, may be a sustainable option, particularly for those avoiding fish, but it is not proven to be superior to fish oil in cancer care outcomes.
I also recommend that my patients aim for an omega-3 index of 8 percent or higher. The omega-3 index is a blood test that measures the percentage of DHA and EPA in red blood cell membranes. Levels of 8 percent or more have been associated with reduced inflammation, better cardiovascular outcomes, and potentially improved cancer resilience. This test offers a simple, objective way to ensure patients are getting enough of these protective fats through diet or supplementation.
🔵Where Fatty Acid Metabolism Is Most Active
Certain cancers rely more heavily on fats:
📍Ovarian, prostate, breast, and liver cancers
📍Tumors with mutations in genes like KRAS, TP53, or MYC
📍Patients with obesity, insulin resistance, or metabolic syndrome
📍Cancers that resist chemotherapy or have spread to other organs
These cancers are especially vulnerable to strategies that disrupt fat metabolism. But this does not mean all fats should be removed. The body still needs fat. The key is to shift the balance away from fats that cancer prefers.
🔵How to Shift the Balance
🌱 🚶Nutrition and Movement:
📍Favor omega-3 fatty acids from flax, chia, walnuts, sardines, and salmon. These help reduce inflammation and disrupt tumor membranes.
📍Limit saturated fats from red meat, butter, and full-fat dairy.
📍Avoid artificial trans fats and processed seed oils high in omega-6 fats.
📍Stay physically active to improve fat metabolism and protect muscle.
💊 Drugs and Supplements Being Studied for Support:
📍Hydroxycitric Acid: Found in Garcinia fruit. Blocks the enzyme that turns sugar into fat.
📍Berberine: A compound from goldenseal and other herbs. Lowers blood lipids and reduces tumor-supportive fat signaling.
📍Curcumin: From turmeric. Blocks enzymes that help cancer make fats.
📍Doxycycline: An antibiotic that may impair fat burning in mitochondria.
📍Fenofibrate: A cholesterol-lowering drug that alters fat metabolism through a receptor called PPAR-alpha.
📍Statins / Red Yeast Rice: Lower cholesterol and reduce cancer-promoting signals.
📍Omega-3s: Help disrupt membranes of tumor cells and reduce inflammation.
📍Artemisinin: Derived from sweet wormwood. May cause fat-based stress that triggers cancer cell death.
📍Orlistat: A weight-loss drug that blocks fat absorption and also inhibits fat-synthesizing enzymes in some tumors. 💩
📍EGCG (Epigallocatechin gallate): A green tea compound shown to reduce fat synthesis and tumor-promoting inflammation.
These are not substitutes for treatment. They are potential allies, helping reshape the terrain in which cancer grows. Always review with your oncology team before adding any of these to your regimen.
🔵Who Might Benefit Most?
Cancers that depend on fats may reveal their weakness through genetic testing. This is where Next-Generation Sequencing (NGS) comes in. It’s a type of testing that analyzes tumor DNA for mutations linked to metabolic dependencies.
Common fat-linked mutations include:
📍MYC: Speeds up fat burning.
📍TP53: Removes normal controls over fat production.
📍KRAS: Increases fat usage during stress, especially during chemotherapy.
If your tumor carries one of these mutations, dietary shifts and fat-targeting strategies may offer added support. Ask your oncologist whether NGS testing, offered by labs like FoundationOne, Tempus, or Guardant, is appropriate for your case.
🔵Final Thought: Starving the Fire Without Starving the Person
Cancer is smart. It adapts. But the very tricks it uses to survive—like stealing fat to fuel itself—can become its undoing.
By understanding which fats help cancer grow and which ones help the body fight back, we open a new front in cancer care. This does not replace conventional treatment. But it offers an additional layer of support, grounded in science, that may tip the balance.
Just as we would not throw gasoline on a fire, we should not feed cancer the fats it thrives on.
*Medical Disclaimer: This article is for educational purposes only. It is not intended to replace conventional cancer treatment or serve as medical advice. Always consult your oncology team before making any changes to your care plan.